Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
NCT00004497
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Pulmonary Hypertension
Interventions
DRUG:
UT-15
Sponsor
United Therapeutics